Certive Solutions Inc. (CBP.CN)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2022 | 2.23 Million USD | -21.75% |
| 2021 | 1.96 Million USD | 50.05% |
| 2020 | 1.31 Million USD | -34.24% |
| 2019 | 1.99 Million USD | -12.82% |
| 2018 | 2.28 Million USD | -27.08% |
| 2017 | 3.14 Million USD | -19.57% |
| 2016 | 3.9 Million USD | -40.52% |
| 2015 | 6.56 Million USD | 167.63% |
| 2014 | 2.45 Million USD | 82.03% |
| 2013 | 1.34 Million USD | 55.0% |
| 2012 | 869.24 Thousand USD | 30.19% |
| 2011 | 667.69 Thousand USD | 380.18% |
| 2010 | 139.05 Thousand USD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2023 Q2 | 347.55 Thousand USD | 14.3% |
| 2023 Q1 | 304.07 Thousand USD | -24.5% |
| 2023 Q3 | 282.92 Thousand USD | -18.59% |
| 2022 Q4 | 402.74 Thousand USD | 19.26% |
| 2022 Q2 | 396.35 Thousand USD | -2.03% |
| 2022 Q3 | 337.7 Thousand USD | -14.8% |
| 2022 FY | 1.54 Million USD | -21.75% |
| 2022 Q1 | 404.55 Thousand USD | -47.37% |
| 2021 Q4 | 768.69 Thousand USD | 64.23% |
| 2021 Q1 | 357.93 Thousand USD | 48.57% |
| 2021 FY | 1.96 Million USD | 50.05% |
| 2021 Q2 | 375.1 Thousand USD | 4.8% |
| 2021 Q3 | 468.06 Thousand USD | 24.78% |
| 2020 Q4 | 240.92 Thousand USD | -31.52% |
| 2020 Q3 | 351.82 Thousand USD | -3.72% |
| 2020 Q2 | 365.43 Thousand USD | 3.05% |
| 2020 Q1 | 354.61 Thousand USD | -23.33% |
| 2020 FY | 1.31 Million USD | -34.24% |
| 2019 Q3 | 526.22 Thousand USD | 11.89% |
| 2019 Q2 | 470.32 Thousand USD | -12.48% |
| 2019 FY | 1.99 Million USD | -12.82% |
| 2019 Q1 | 537.41 Thousand USD | -52.45% |
| 2019 Q4 | 462.52 Thousand USD | -12.11% |
| 2018 Q3 | 370.8 Thousand USD | 13.14% |
| 2018 Q2 | 327.73 Thousand USD | -28.94% |
| 2018 Q4 | 1.13 Million USD | 204.81% |
| 2018 Q1 | 461.2 Thousand USD | -45.32% |
| 2018 FY | 2.28 Million USD | -27.08% |
| 2017 Q3 | 699.29 Thousand USD | -18.66% |
| 2017 FY | 3.14 Million USD | -19.57% |
| 2017 Q4 | 843.41 Thousand USD | 20.61% |
| 2017 Q2 | 859.7 Thousand USD | 8.76% |
| 2017 Q1 | 790.44 Thousand USD | -20.95% |
| 2016 FY | 3.9 Million USD | -40.52% |
| 2016 Q4 | 999.87 Thousand USD | 1.38% |
| 2016 Q2 | 1.03 Million USD | 19.61% |
| 2016 Q1 | 864.16 Thousand USD | -72.37% |
| 2016 Q3 | 986.31 Thousand USD | -4.58% |
| 2015 FY | 6.56 Million USD | 167.63% |
| 2015 Q2 | 1.61 Million USD | 152.67% |
| 2015 Q3 | 1.18 Million USD | -26.65% |
| 2015 Q4 | 3.12 Million USD | 164.2% |
| 2015 Q1 | 638.74 Thousand USD | -51.8% |
| 2014 Q2 | 334.29 Thousand USD | -64.77% |
| 2014 FY | 2.45 Million USD | 82.03% |
| 2014 Q4 | 1.32 Million USD | 135.22% |
| 2014 Q3 | 563.41 Thousand USD | 68.54% |
| 2014 Q1 | 948.93 Thousand USD | 183.24% |
| 2013 Q4 | 335.02 Thousand USD | -11.06% |
| 2013 FY | 1.34 Million USD | 55.0% |
| 2013 Q1 | 442.61 Thousand USD | 2837.59% |
| 2013 Q2 | 205.95 Thousand USD | -53.47% |
| 2013 Q3 | 376.68 Thousand USD | 82.9% |
| 2012 Q2 | 421.1 Thousand USD | -3.62% |
| 2012 Q1 | 436.92 Thousand USD | -31.36% |
| 2012 FY | 869.24 Thousand USD | 30.19% |
| 2012 Q3 | 178.49 Thousand USD | -57.61% |
| 2012 Q4 | 15.06 Thousand USD | -91.56% |
| 2011 Q2 | 8465.04 USD | 46.26% |
| 2011 Q3 | 10.4 Thousand USD | 22.97% |
| 2011 Q4 | 636.58 Thousand USD | 6015.64% |
| 2011 FY | 667.69 Thousand USD | 380.18% |
| 2011 Q1 | 5787.83 USD | -95.07% |
| 2010 FY | 139.05 Thousand USD | 0.0% |
| 2010 Q3 | 2827.20 USD | -84.42% |
| 2010 Q2 | 18.14 Thousand USD | 0.0% |
| 2010 Q4 | 117.3 Thousand USD | 4049.22% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| AI/ML Innovations Inc. | 1.95 Million CAD | -14.238% |
| Diagnamed Holdings Corp. | 1.17 Million CAD | -90.103% |
| Pangenomic Health Inc. | 2.03 Million CAD | -10.266% |
| nDatalyze Corp. | 381.76 Thousand CAD | -486.433% |
| Treatment.Com International Inc. | 2.32 Million CAD | 3.789% |
| Unidoc Health Corp. | 2.13 Million CAD | -4.989% |